scholarly journals COST-EFFECTIVENESS OF CARDIOVASCULAR RISK CLASSIFICATION BASED ON ANKLE-BRACHIAL INDEX TEST IN ASSOCIATION TO FRAMINGHAM RISK SCORE

2021 ◽  
Vol 39 (Supplement 1) ◽  
pp. e274
Author(s):  
Alessandro Maloberti ◽  
Paolo Cortesi ◽  
M. Micale ◽  
G. Mazzaglia ◽  
Lucia Occhi ◽  
...  
Keyword(s):  
Cardiovascular Risk ◽  
Cost Effectiveness ◽  
Risk Score ◽  
Framingham Risk Score ◽  
Ankle Brachial Index ◽  
Risk Classification ◽  
Index Test ◽  
Framingham Risk

scholarly journals Adding carotid total plaque area to the Framingham risk score improves cardiovascular risk classification

2016 ◽  
Vol 3 ◽  
pp. 513-520 ◽  
Author(s):  
Hernan A. Perez ◽  
Nestor Horacio Garcia ◽  
John David Spence ◽  
Luis J. Armando
Keyword(s):  
Cardiovascular Risk ◽  
Risk Score ◽  
Framingham Risk Score ◽  
Risk Classification ◽  
Plaque Area ◽  
Framingham Risk ◽  
Total Plaque Area

scholarly journals A Retrospective Exploratory Analysis on Cardiovascular Risk and Cognitive Dysfunction in Multiple Sclerosis

2021 ◽  
Vol 11 (4) ◽  
pp. 502
Author(s):  
Antonio Reia ◽  
Martina Petruzzo ◽  
Fabrizia Falco ◽  
Teresa Costabile ◽  
Matteo Conenna ◽  
...  
Keyword(s):  
Cardiovascular Risk ◽  
Cognitive Function ◽  
Risk Score ◽  
Framingham Risk Score ◽  
Verbal Learning ◽  
Macrovascular Disease ◽  
Cardiovascular Comorbidities ◽  
Cholesterol Levels ◽  
Framingham Risk ◽  
Input Variables

Background. Cardiovascular comorbidities have been associated with cognitive decline in the general population. Objectives. To evaluate the associations between cardiovascular risk and neuropsychological performances in MS. Methods. This is a retrospective study, including 69 MS patients. For all patients, we calculated the Framingham risk score, which provides the 10-year probability of developing macrovascular disease, using age, sex, diabetes, smoking, systolic blood pressure, and cholesterol levels as input variables. Cognitive function was examined with the Brief International Cognitive Assessment for MS (BICAMS), including the Symbol Digit Modalities Test (SDMT), the California Verbal Learning Test-II (CVLT-II), and the Brief Visuospatial Memory Test-Revised (BVMT-R). Results. Each point increase of the Framingham risk score corresponded to 0.21 lower CVLT-II score. Looking at Framingham risk score components, male sex and higher total cholesterol levels corresponded to lower CVLT scores (Coeff = −8.54; 95%CI = −15.51, −1.57; and Coeff = −0.11; 95%CI = −0.20, −0.02, respectively). No associations were found between cardiovascular risk and SDMT or BVMT-R. Conclusions. In our exploratory analyses, cardiovascular risk was associated with verbal learning dysfunction in MS. Lifestyle and pharmacological interventions on cardiovascular risk factors should be considered carefully in the management of MS, given the possible effects on cognitive function.

Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score

2013 ◽  
Vol 167 (6) ◽  
pp. 2904-2911 ◽  
Author(s):  
Stig Lyngbæk ◽  
Jacob L. Marott ◽  
Thomas Sehestedt ◽  
Tine W. Hansen ◽  
Michael H. Olsen ◽  
...  
Keyword(s):  
Cardiovascular Risk ◽  
General Population ◽  
Risk Prediction ◽  
Risk Score ◽  
Framingham Risk Score ◽  
Framingham Risk ◽  
Cardiovascular Risk Prediction

scholarly journals Baseline Framingham risk score does not predict future ECG-derived QRS duration over an average of 3.3 years

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Elijah Stone ◽  
Yuling Zhou ◽  
Herbert Jelinek ◽  
Craig S. Mclachlan
Keyword(s):  
Cardiovascular Risk ◽  
Risk Score ◽  
Framingham Risk Score ◽  
Cross Sectional ◽  
Online Risk ◽  
Weak Association ◽  
Framingham Risk ◽  
Qrs Duration ◽  
Risk Parameters

Abstract Background Prolonged electrocardiogram (ECG) QRS duration has been associated with increased cardiovascular risk. It is unclear whether the main predictor of cardiovascular risk, the Framingham risk score also predicts short-term changes in ECG QRS duration. Our aim is to determine whether baseline Framingham risk score is associated with baseline or changes in QRS duration. Methods A retrospective cross-sectional analysis was performed using observational data obtained from two hundred two participants. Framingham risk score was calculated using an online risk calculator. QRS duration was obtained using a 10 s trace from a Welch Allyn PC-based 12-lead ECG system. Results Average follow-up duration was 3.3 ± 1.1 years. Mean QRS change was 1.8 ± 11.4 ms. Specifically, among two hundred two participants, there are 104 subjects with a greater QRS duration at follow-up, while 98 subjects had the same or a shorter follow-up QRS duration. Baseline Framingham risk score did not significantly predict an increase in QRSd with an odds ratio of 1.04 (P = 0.230). Regression analysis of QRS duration at baseline and Framingham risk at baseline had a weak association (R2 = 0.020; P = 0.043). The Framingham risk score at follow-up was likewise has a weak association with follow-up QRS duration (R2 = 0.045; P = 0.002). Conclusions Our results do not demonstrate a statistically significant association between Framingham risk parameters and future QRS duration changes over longitudinal time. QRS duration had variable changes between baseline and follow-up. This might suggest that a longer period of follow-up is required to document more stable increases in QRS duration associated with ventricular pathology. A larger population study is needed to confirm our observations.

Sign in / Sign up

Export Citation Format

Share Document